Overton Brooks Research Corporation

“The board of directors will be given the opportunity to review and approve the annual irs form 990 information return at least two weeks before the filing date. Executive director: is paid a nominal amount for reviewing documents/policies/budget, signing correspondence, mandatory training, conducting meetings and approving purchase orders at a rate of pay at $40.00 per hour. Also: principal investigators: federal law title 18 usc 209(a) prohibits a va investigator from receiving salary or any contribution to or supplementation of salary from any source other than the united states. Board members: obrc currently does not provide any type of compensation for members of the board of directors. There is no compensation for teavel expenses to attend meeting of the board. The entity makes its governing documents, conflict of interest policy, and financial statements available to the public upon request.”

“The board of directors will be given the opportunity to review and approve the annual irs form 990 information return at least two weeks before the filing date.”

“Executive director: is paid a nominal amount for reviewing documents/policies/budget, signing correspondence, mandatory training, conducting meetings and approving purchase orders at a rate of pay at $40.00 per hour. Also: principal investigators: federal law title 18 usc 209(a) prohibits a va investigator from receiving salary or any contribution to or supplementation of salary from any source other than the united states. Board members: obrc currently does not provide any type of compensation for members of the board of directors. There is no compensation for teavel expenses to attend meeting of the board.”

“The entity makes its governing documents, conflict of interest policy, and financial statements available to the public upon request.”

“The corporation regularly takes on new research projects that mist be approved in accordance with procedures prescribed for formal review by the va medical center research and development committee. Novartis pharmaceuticals corporation study qi23-001 with dr. Sandra brown as principal investigator. (1) this study contacts veterans receiving care at overton brooks vamc concerning their cholesterol levels. Ther are over 37,000 veterans serves at this facility. (2) the long-term goal is to improve the cholesterol health through contact with a health care coach. (3) this is a multi-site study with no fixed statistical goal other than to apply existing knowledge to develop individualized care solutions to lower cholesterol in the veteran population. This is not research requiring institutional review board review.”

“The sole purpose of the corporation is to support and facilitate medical research activities of its members in conjunction with the overton brooks veterans affair medical center.”